PHGE
PHGE
AMEX · Biotechnology

Biomx Inc

$0.58
-0.04 (-6.53%)
As of May 16, 2:33 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +3,516.9% upside
Low Target $13.63
Average Target $21.13
High Target $23.51
Current Price $0.58
Current
$0.58
Target
$21.13
$13.63 $21.13 avg $23.51
Scenario Analysis
Bear Case
$13.63
2,233.1%
Low target
Base Case
$21.13
+3,516.9%
Avg target
Bull Case
$23.51
+3,924.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$14.71
-96.0% from high
52-Week Low
$0.58
+1.2% from low
Target vs 52W High
$21.13
+43.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%